156 related articles for article (PubMed ID: 12109653)
1. Abnormal regional cerebral blood flow in primary antiphospholipid antibody syndrome patients with normal magnetic resonance imaging findings. A preliminary report.
Chen JJ; Shiau YC; Wang JJ; Ho ST; Kao A
Scand J Rheumatol; 2002; 31(2):89-93. PubMed ID: 12109653
[TBL] [Abstract][Full Text] [Related]
2. Evaluation of regional cerebral blood flow with 99mTc-HMPAO in primary antiphospholipid antibody syndrome.
Kao CH; Lan JL; Hsieh JF; Ho YJ; ChangLai SP; Lee JK; Ding HJ
J Nucl Med; 1999 Sep; 40(9):1446-50. PubMed ID: 10492363
[TBL] [Abstract][Full Text] [Related]
3. Abnormal regional cerebral blood flow found by technetium-99m ethyl cysteinate dimer brain single photon emission computed tomography in systemic lupus erythematosus patients with normal brain MRI findings.
Chen JJ; Yen RF; Kao A; Lin CC; Lee CC
Clin Rheumatol; 2002 Nov; 21(6):516-9. PubMed ID: 12447638
[TBL] [Abstract][Full Text] [Related]
4. Abnormal regional cerebral blood flow on 99mTc ECD brain SPECT in patients with primary Sjögren's syndrome and normal findings on brain magnetic resonance imaging.
Chang CP; Shiau YC; Wang JJ; Ho ST; Kao A
Ann Rheum Dis; 2002 Sep; 61(9):774-8. PubMed ID: 12176800
[TBL] [Abstract][Full Text] [Related]
5. Using 99mTc HMPAO brain SPECT to evaluate the effects of anticoagulant therapy on regional cerebral blood flow in primary antiphospholipid antibody syndrome patients with brain involvement-a preliminary report.
Sun SS; Liu FY; Tsai JJ; Yen RF; Kao CH; Huang WS
Rheumatol Int; 2003 Nov; 23(6):301-4. PubMed ID: 12684837
[TBL] [Abstract][Full Text] [Related]
6. Usefulness of Tc-99m ECD brain SPECT to evaluate the effects of methylprednisolone pulse therapy in lupus erythematosus with brain involvement: a preliminary report.
Liu FY; Huang WS; Kao CH; Yen RF; Wang JJ; Ho ST
Rheumatol Int; 2003 Jul; 23(4):182-5. PubMed ID: 12856144
[TBL] [Abstract][Full Text] [Related]
7. Detecting abnormal regional cerebral blood flow in patients with primary Sjögren's syndrome by technetium-99m ethyl cysteinate dimer single photon emission computed tomography of the brain--a preliminary report.
Huang WS; Chiu PY; Kao A; Tsai CH; Lee CC
Rheumatol Int; 2003 Jul; 23(4):174-7. PubMed ID: 12856142
[TBL] [Abstract][Full Text] [Related]
8. Decreased cerebral blood flow in neuro-Behçet's syndrome patients with neuropsychiatric manifestations and normal magnetic resonance imaging--a preliminary report.
Huang WS; Chiu PY; Kao A; Tsai CH; Lee CC
J Neuroimaging; 2002 Oct; 12(4):355-9. PubMed ID: 12380483
[TBL] [Abstract][Full Text] [Related]
9. Objective evidence of abnormal regional cerebral blood flow in patients with systemic lupus erythematosus on Tc-99m ECD brain SPECT.
Huang WS; Chiu PY; Tsai CH; Kao A; Lee CC
Rheumatol Int; 2002 Sep; 22(5):178-81. PubMed ID: 12215861
[TBL] [Abstract][Full Text] [Related]
10. Technetium-99m-ECD SPECT in antiphospholipid antibody syndrome: a drastic improvement in brain perfusion by antiplatelet therapy.
Tokumaru S; Yoshikai T; Uchino A; Matsui M; Kuroda Y; Kudo S
Eur Radiol; 2001; 11(12):2611-5. PubMed ID: 11734968
[TBL] [Abstract][Full Text] [Related]
11. A higher prevalence of abnormal regional cerebral blood flow in patients with syndrome X and abnormal myocardial perfusion.
Pai PY; Liu FY; Kao A; Lin CC; Lee CC
Jpn Heart J; 2003 Mar; 44(2):145-52. PubMed ID: 12718477
[TBL] [Abstract][Full Text] [Related]
12. Concordance between (99m)Tc-ECD SPECT and 18F-FDG PET interpretations in patients with cognitive disorders diagnosed according to NIA-AA criteria.
Ito K; Shimano Y; Imabayashi E; Nakata Y; Omachi Y; Sato N; Arima K; Matsuda H
Int J Geriatr Psychiatry; 2014 Oct; 29(10):1079-86. PubMed ID: 24687634
[TBL] [Abstract][Full Text] [Related]
13. Increased heterogeneity of brain perfusion is an early marker of central nervous system involvement in antiphospholipid antibody carriers.
Lin TS; Hsu PY; Chang CH; Ko CL; Kuo YM; Wu YW; Yen RF; Wu CH; Li KJ; Hsein YC; Hsieh SC
PLoS One; 2017; 12(8):e0182344. PubMed ID: 28763503
[TBL] [Abstract][Full Text] [Related]
14. Cognitive function and 99mTc-ECD brain SPECT are significantly correlated in patients with primary Sjogren syndrome: a case-control study.
Le Guern V; Belin C; Henegar C; Moroni C; Maillet D; Lacau C; Dumas JL; Vigneron N; Guillevin L
Ann Rheum Dis; 2010 Jan; 69(1):132-7. PubMed ID: 19158115
[TBL] [Abstract][Full Text] [Related]
15. SPECT imaging of normal subjects with technetium-99m-HMPAO and technetium-99m-ECD.
Koyama M; Kawashima R; Ito H; Ono S; Sato K; Goto R; Kinomura S; Yoshioka S; Sato T; Fukuda H
J Nucl Med; 1997 Apr; 38(4):587-92. PubMed ID: 9098207
[TBL] [Abstract][Full Text] [Related]
16. [Arterial clearance and cerebral uptake of Tc-99m ECD in patients with cerebrovascular disease compared with PET].
Shishido F; Uemura K; Murakami M; Inugami A; Ogawa T; Higano S; Fujita H; Shimosegawa E; Kanno I; Aizawa Y
Kaku Igaku; 1992 Jan; 29(1):27-35. PubMed ID: 1578819
[TBL] [Abstract][Full Text] [Related]
17. Regional cerebral blood flow between primary and concomitant fibromyalgia patients: a possible way to differentiate concomitant fibromyalgia from the primary disease.
Chen JJ; Wang JY; Chang YM; Su SY; Chang CT; Sun SS; Kao CH; Lee CC
Scand J Rheumatol; 2007; 36(3):226-32. PubMed ID: 17657679
[TBL] [Abstract][Full Text] [Related]
18. Persistent brain damage in reversible cerebral vasoconstriction syndrome on
Kunitake K; Ogura A; Iwata-Hatanaka M; Inagaki R; Furukawa S; Suzuki J; Nakai N; Nishida S; Katsuno M; Ito Y
J Neurol Sci; 2022 Nov; 442():120441. PubMed ID: 36209569
[TBL] [Abstract][Full Text] [Related]
19. Correlation of Tc-99 m ethyl cysteinate dimer single-photon emission computed tomography and clinical presentations in patients with low cobalamin status.
Tu MC; Lo CP; Chen CY; Huang CF
BMC Neurol; 2015 Dec; 15():251. PubMed ID: 26630935
[TBL] [Abstract][Full Text] [Related]
20. SPECT images of technetium-99m-ethyl cysteinate dimer in cerebrovascular diseases: comparison with other cerebral perfusion tracers and PET.
Tsuchida T; Nishizawa S; Yonekura Y; Sadato N; Iwasaki Y; Fujita T; Matoba N; Magata Y; Tamaki N; Konishi J
J Nucl Med; 1994 Jan; 35(1):27-31. PubMed ID: 8271056
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
